Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.M. Laxer, B.M. Feldman.
General and local scleroderma in children and dermatomyositis and associated syndromes.
Curr Opin Rheumatol, 9 (1997), pp. 458-464
[2.]
S. Jablonska, M. Blaszczyk.
Scleroderma overlap syndromes.
Adv Exp Med Biol, 455 (1999), pp. 85-92
[3.]
Subcommittee for Scleroderma Criteria of the American Rheumatism Association diagnostic and therapeutic committee.
Preliminary criteria for the classification of systemic sclerosis (scleroderma).
Arthritis Rheum, 23 (1980), pp. 581-590
[4.]
A. Bohan, J.B. Peter.
Polymyositis and dermatomyositis: parts 1 and 2.
N Engl J Med, 292 (1975), pp. 344-347
[5.]
J.H. Park, C.W. Lee.
Concurrent development of dermatomyositis and morphoea profunda.
Clin Exp Dermatol, 27 (2002), pp. 324-327
[6.]
Y. Uziel, B.R. Krafchik, E.D. Silverman, P.S. Thorner, R.M. Laxer.
Localized scleroderma in childhood: a report of 30 cases.
Semin Arthritis Rheum, 23 (1994), pp. 328-340
[7.]
T. Mike, Y. Ohtani, S. Hattori, T. Ono, T. Kageshita, I. Matsuda.
Childhood-type myositis and linear scleroderma.
Neurology, 33 (1983), pp. 928-930
[8.]
U. Runne, K. Fasshauer.
Idiopathische und sklerodermische Hemiatrophia faciei mit generalisierter myopathie.
Der Haudarzt, 28 (1977), pp. 10-17
[9.]
J.W. Dunne, N. Heye, R.H. Edis, B.A. Kakulas.
Necrotizing inflammatory myopathy associated with localized scleroderma.
Muscle & Nerve, 19 (1996), pp. 1040-1042
Copyright © 2006. Elsevier España S.L. Barcelona
